Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without CirrhosisKris V. Kowdley, Michael Fried, David Pound et al.|New England Journal of Medicine|2014Cited by 1.1k
686 EFFECTS ON PRURITUS AND SLEEP DISTURBANCE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC) AFTER 1 YEAR OF TREATMENT WITH SELADELPAR, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA AGONIST: RESULTS OF AN OPEN-LABEL PHASE 2 STUDYAndreas E. Kremer, Yun‐Jung Choi, Ke Yang et al.|Gastroenterology|2020Cited by 1